D
uring my tenure as the Associate Editor of the International Society of Nephrology's (ISN's) flagship journal Kidney International (KI), I was struck by the sheer volume of high-quality research papers that were turned away as "priority rejections" due to space limitations. The need for an alternative publishing outlet for important studies that would interest KI readers soon became self-evident. As a result, the ISN has decided to launch a second journal-one with an open-access format and a greater clinical focus to meet the needs of the growing international nephrology community.
In considering the launch of a new journal, the publication model required extensive consideration. The structure by which scientific publishing generates revenue can pose challenges to authors and readers alike. Many traditional subscription-based journals (with print and electronic content) require publication charges for authors and subscription fees for readers. These costs are usually paid for by academic medical centers, research funding bodies, or medical societies that provide publications as part of employment or membership. Yet, this business model creates artificial barriers to the exchange of scientific knowledge. After all, most of us have, at some point, been approached by colleagues for reprints of articles to which they would not otherwise have access. Reuse of materials from these journals is considered another source of revenue and, as a result, is usually restricted.
That said, a major shift has taken place in recent years regarding how readers view published content. a peer-reviewed "gold" OA format, offering full and immediate access to all content without a paywall or other restrictions. Relevant content will encompass the broad spectrum of clinical and translational research. The journal will use novel technologies that take advantage of the Webbased medium to enhance the experience of authors and readers, including the use of online content innovations. rapid time to publication-an average of 1 week from acceptance to online publication of the accepted manuscript version of articles. Further, KI Reports will offer the latest news and insight on clinical and translational research topics in real time on a continual basis on our website (www.kireports.org), as well as on the ISN's social media platforms, including Facebook, Twitter, and LinkedIn. for a limited time, steeply discounted publication charges will be available to authors, with Jai Radhakrishan, Editor-in-Chief, KI Reports an additional discount for ISN members. Color images will be published free of charge on a permanent basis. Further, in keeping with the ISN's mission to combat kidney disease as a global initiative, article processing charges will be waived for accepted papers from regions considered to be economically distressed (per the WHO/HINARI guidelines). The success of KI Reports depends on authors who are willing to submit their best work, and readers who will continue to expect the high quality that KI has come to represent. While we have already begun to receive submissions, we welcome articles describing study protocols, phase I trials, meta-analyses, case reports, and systematic reviews of the current literature. Research articles on education techniques, socio-medical sciences, public health, and pharmacology, as they relate to nephrology and patient care, are also of interest to the editorial board of KI Reports. In addition, KI Reports will act as a publishing platform for national and regional guidelines and reports from key meetings and symposia.
With Elsevier as the publisher of KI Reports, authors can expect to have a high-quality and smooth production process for their important contributions. The KI Reports editorial team brings together decades of exceptional experience, as well as thought leaders in the many diverse clinical, research, public health, and policy areas of nephrology.
On behalf of the editorial team and publisher, I look forward to your active participation as both readers and submitting authors.
